Exhibit 99.1
| Amended Loan Schedule to Secured Promissory Note dated November 10, 2022 |
| between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC |
| | | | |
| | Date | Principal | Aggregated Principal |
| Original Secured Promissory Note | 11/10/2022 | $2,319,279 | $2,319,279 |
| Additional loans to be included: | | | |
| Loan #1 | 12/22/2022 | $250,000 | $2,569,279 |
| Loan #2 | 1/19/2023 | $250,000 | $2,819,279 |
| Loan #3 | 2/22/2023 | $250,000 | $3,069,279 |
| Loan #4 | 3/20/2023 | $250,000 | $3,319,279 |
| Loan #5 | 5/19/2023 | $150,000 | $3,469,279 |
| Loan #6 | 7/10/2023 | $200,000 | $3,669,279 |
| Loan #7 | 7/28/2023 | $250,000 | $3,919,279 |
| Loan #8 | 8/30/2023 | $250,000 | $4,169,279 |
| Loan #9 | 10/11/2023 | $250,000 | $4,419,279 |
| Loan #10 | 12/04/2023 | $250,000 | $4,669,279 |
| Loan #11 | 1/08/2024 | $250,000 | $4,919,279 |
| Loan #12 | 2/14/2024 | $250,000 | $5,169,279 |
| Loan #13 | 3/14/2024 | $250,000 | $5,419,279 |
| Loan #14 | 5/10/2024 | $200,000 | $5,619,279 |
| Loan #15 | 6/03/2024 | $75,000 | $5,694,279 |
| Loan #16 | 6/14/2024 | $200,000 | $5,894,279 |
| Loan #17 | 7/03/2024 | $150,000 | $6,044,279 |
| Loan #18 | 7/22/2024 | $100,000 | $6,144,279 |
| Loan #19 | 8/19/2024 | $125,000 | $6,269,279 |
| Loan #20 | 9/20/2024 | $100,000 | $6,369,279 |
| Loan #21 | 9/30/2024 | $150,000 | $6,519,279 |
| Loan #22 | 10/11/2024 | $100,000 | $6,619,279 |
| Loan #23 | 10/28/2024 | $100,000 | $6,719,279 |
ACURA PHARMACEUTICALS, INC.
By: /s/ Robert A. Seiser
Robert A. Seiser
Senior Vice President & Chief Financial Officer
Date: November 2, 2024
